Home / Recalls / X-Gen Pharmaceuticals Inc. / D-1059-2017

D-1059-2017 Class II Terminated

Recalled by X-Gen Pharmaceuticals Inc. — Horseheads, NY

Recall Details

Product Type
Drugs
Report Date
August 16, 2017
Initiation Date
May 17, 2017
Termination Date
September 5, 2018
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
9,816 bottles

Product Description

Nystatin Topical Powder, USP, 100,000 USP units per gram, 15 grams per bottle, Rx only, Vensun, NDC 42543-052-61

Reason for Recall

Presence of Foreign Substance: potential presence of plastic particles.

Distribution Pattern

Nationwide in the US

Code Information

Lot #: 23701.158A, EXP 10/31/18

Other recalls by X-Gen Pharmaceuticals Inc.

  • D-0433-2024 Class III — Cyclophosphamide for Injection, USP, 500mg/vial, Lyophilized, Cytotoxic Agent, S (April 2, 2024)
  • D-0434-2024 Class III — Cyclophosphamide for Injection, USP, 1g/vial, Lyophilized, Single Dose Vial, Dis (April 2, 2024)
  • D-0328-2021 Class II — Neomycin Sulfate Tablets, USP 500mg, Rx Only, 10x10 Unit dose 100 Tablets, Manu (March 19, 2021)
  • D-0519-2020 Class III — Levetiracetam Injection, 500 mg/5mL, 10 single-use 5 mL vials, Rx only, Manufact (October 11, 2019)
  • D-1084-2019 Class III — Clonidine HCL Injection, 1000 mcg/10mL (100 mcg/mL), 10 ML Single Dose Vial, Rx (March 29, 2019)
  • D-0637-2017 Class I — Ibuprofen Lysine Injection, 20 mg/2 mL (10 mg/mL), 2 mL Single-Dose Vial (NDC 39 (February 8, 2017)
  • D-1444-2014 Class III — Clonidine HCl Injection, 1000 mcg/10 mL (100 mcg/mL),10 mL Single Dose Vial, Rx (July 17, 2014)